FDA ANDA · ANDA202581

QUININE SULFATE

Sponsor: AUROBINDO PHARMA USA

APPLICATION

ANDA202581

TYPE

ANDA

ORIGINAL APPROVAL

2012-12-14

LATEST ACTION

2015-12-04

ROUTE

ORAL

DOSAGE FORM

CAPSULE

MARKETING STATUS

Discontinued

Products

QUININE SULFATEDiscontinued

QUININE SULFATE 324MG · CAPSULE · ORAL

2015-12-04Labeling · Supplement 4 · standardAP

2013-07-11Labeling · Supplement 3 · standardAP

2013-04-23Labeling · Supplement 1 · standardAP

2012-12-14UNKNOWN · OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.